Jordan Meggison-Decker

Who Owns the Intellectual Property Rights Associated with Hydroxychloroquine?

As efforts to discover new treatments for COVID-19 continue, attention has been brought upon an old drug, hydroxychloroquine. The renewed attention follows several statements by the Federal Drug Administration (“FDA”) and issuance of an Emergency Use Authorization for use of hydroxychloroquine from the national stockpile for treatment of COVID-19.... Read More

Protecting Trade Secrets During a Pandemic

In response to the COVID-19 pandemic, many employers have been forced to require employees to work remotely. Requiring large numbers of people to work from home helps limit the spread of the virus and enables business to continue. However, employees working remotely can pose challenges to a company’s valuable trade secrets. Trade secrets can be a... Read More